Treatment Protocol for the Use of Sorafenib in Patients With Advanced Renal Cell Carcinoma

Clinical trial NCT00111020 · COMPLETED

Trial details

NCT number: NCT00111020
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoma, Renal Cell

Start date: 2005-06-01
Primary completion: 2007-06-01
Enrollment: 2567

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.